Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Assessment of [an Albuterol] Hydrofluoroalkane (HFA) Metered Dose Inhaler MDI Integrated Dose Counter

NCT01302587 is registered in ClinicalTrials.gov with Teva Branded Pharmaceutical Products R&D, Inc. as lead sponsor.

NCT NCT01302587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01302587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Assessment of [an Albuterol] Hydrofluoroalkane (HFA) Metered Dose Inhaler MDI Integrated Dose Counter
Lead sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
June 30, 2011
Enrollment
306 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), emphysema